Nifty

:

17094.35

Sensex

:

57426.92

276.25 (1.64%)
1016.96 (1.80%)

Login

Nifty
Sensex

:
:

17094.35
57426.92

276.25 (1.64%)
1016.96 (1.80%)

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

38/99

BSE: 524396 | NSE: BIOFILCHEM

Watchlist

NSE BSE

47.80

30-Sep-2022

Day's Open
Day's High
Day's Low
Previous Close

47.90
48.50
47.60
47.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

7374
3.53
107.00
39.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

77.54
106.08
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

77.86
N/A
4.55

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.05
12.61
-8.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

2.79
7.19
-6.08

PAT CAGR (%)

10 Years
5 Years
3 Years

2.63
8.29
-16.68

P:E (Median)

8 Years
5 Years
3 Years

20.22
34.04
85.52

P:BV (Average)

8 Years
5 Years
3 Years

6.65
6.65
6.65

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.60
33.44
46.85

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 12.31 5.37 129.24% 1.65 14.24 -88.41% 1.63 3.19 -48.90% 13.74 16.02 -14.23%
Expenses 11.93 5.04 136.71% 1.50 13.87 -89.19% 1.14 2.58 -55.81% 13.37 15.11 -11.52%
EBITDA 0.38 0.33 15.15% 0.14 0.37 -62.16% 0.49 0.61 -19.67% 0.37 0.91 -59.34%
EBIDTM 3.06% 6.18% 8.63% 2.61% 29.82% 19.11% 2.72% 5.67%
Other Income 0.02 0.02 0.00% 0.03 0.00 0 0.07 0.02 250.00% 0.03 0.15 -80.00%
Interest 0.01 0.01 0.00% 0.01 -0.09 - 0.01 0.11 -90.91% 0.01 0.02 -50.00%
Depreciation 0.11 0.10 10.00% 0.12 0.19 -36.84% 0.10 0.01 900.00% 0.10 0.11 -9.09%
PBT 0.28 0.24 16.67% 0.04 0.26 -84.62% 0.44 0.51 -13.73% 0.29 0.93 -68.82%
Tax 0.07 0.07 0.00% 0.07 0.68 -89.71% 0.10 0.00 0 0.08 0.00 0
PAT 0.21 0.17 23.53% -0.03 -0.42 - 0.34 0.51 -33.33% 0.21 0.93 -77.42%
PATM 1.68% 3.24% -1.76% -2.91% 20.86% 16.01% 1.55% 5.78%
EPS 0.13 0.11 18.18% -0.02 -0.25 - 0.21 0.31 -32.26% 0.13 0.57 -77.19%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 29.33 22.38 35.75 29.69 23.13 12.36 13.45 13.17 5.86 7.17 6.01 Net Sales Growth -24.45% -37.40% 20.41% 28.36% 87.14% -8.10% 2.13% 124.74% -18.27% 19.30% Cost Of Goods Sold 26.35 19.46 32.43 25.31 19.99 9.77 8.51 10.53 3.85 4.73 3.71 Gross Profit 2.98 2.92 3.32 4.38 3.14 2.59 4.94 2.65 2.01 2.44 2.30 GP Margin 10.15% 13.05% 9.29% 14.75% 13.58% 20.95% 36.73% 20.12% 34.30% 34.03% 38.27% Total Expenditure 27.94 21.05 34.15 27.87 22.11 11.42 10.83 12.30 5.13 6.21 5.00 Power & Fuel Cost - 0.30 0.29 0.49 0.37 0.33 0.44 0.37 0.35 0.28 0.37 % Of Sales - 1.34% 0.81% 1.65% 1.60% 2.67% 3.27% 2.81% 5.97% 3.91% 6.16% Employee Cost - 0.79 0.75 0.86 0.89 0.73 0.53 0.48 0.50 0.41 0.43 % Of Sales - 3.53% 2.10% 2.90% 3.85% 5.91% 3.94% 3.64% 8.53% 5.72% 7.15% Manufacturing Exp. - 0.15 0.30 0.55 0.20 0.14 0.47 0.49 0.19 0.27 0.20 % Of Sales - 0.67% 0.84% 1.85% 0.86% 1.13% 3.49% 3.72% 3.24% 3.77% 3.33% General & Admin Exp. - 0.30 0.29 0.24 0.24 0.39 0.48 0.32 0.16 0.15 0.20 % Of Sales - 1.34% 0.81% 0.81% 1.04% 3.16% 3.57% 2.43% 2.73% 2.09% 3.33% Selling & Distn. Exp. - 0.01 0.01 0.38 0.39 0.04 0.31 0.06 0.00 0.29 0.01 % Of Sales - 0.04% 0.03% 1.28% 1.69% 0.32% 2.30% 0.46% 0% 4.04% 0.17% Miscellaneous Exp. - 0.05 0.08 0.03 0.02 0.02 0.09 0.05 0.08 0.07 0.01 % Of Sales - 0.22% 0.22% 0.10% 0.09% 0.16% 0.67% 0.38% 1.37% 0.98% 1.16% EBITDA 1.38 1.33 1.60 1.82 1.02 0.94 2.62 0.87 0.73 0.96 1.01 EBITDA Margin 4.71% 5.94% 4.48% 6.13% 4.41% 7.61% 19.48% 6.61% 12.46% 13.39% 16.81% Other Income 0.15 0.15 0.80 0.17 0.10 0.10 0.14 0.53 0.46 0.06 0.06 Interest 0.04 0.04 0.07 0.12 0.16 0.15 0.16 0.15 0.21 0.15 0.19 Depreciation 0.43 0.43 0.41 0.41 0.37 0.30 0.28 0.26 0.25 0.22 0.21 PBT 1.05 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 0.65 0.67 Tax 0.32 0.32 0.68 0.26 0.12 0.12 0.52 0.20 0.15 0.13 0.13 Tax Rate 30.48% 31.68% 35.42% 17.81% 20.00% 20.34% 22.51% 20.41% 20.27% 20.00% 19.40% PAT 0.73 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 0.52 0.54 PAT before Minority Interest 0.73 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 0.52 0.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.49% 3.13% 3.47% 4.08% 2.08% 3.80% 13.31% 5.92% 10.07% 7.25% 8.99% PAT Growth -38.66% -43.55% 2.48% 152.08% 2.13% -73.74% 129.49% 32.20% 13.46% -3.70% EPS 0.45 0.43 0.76 0.74 0.29 0.29 1.10 0.48 0.36 0.32 0.33

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 16.84 16.13 14.88 13.65 13.17 12.70 10.91 8.41 7.86 7.36 Share Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 Total Reserves 0.56 -0.14 -1.39 -2.62 -3.11 -3.58 -5.37 -7.86 -8.41 -8.91 Non-Current Liabilities 0.40 0.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 1.49 16.75 27.48 10.56 10.99 9.14 13.23 5.34 6.74 6.13 Trade Payables 0.60 15.85 25.92 8.58 9.14 7.10 11.59 2.11 3.64 3.11 Other Current Liabilities 0.16 0.14 0.12 0.23 0.17 0.12 0.00 0.00 0.00 0.00 Short Term Borrowings 0.46 0.43 1.19 1.64 1.56 1.43 1.37 2.98 2.87 2.79 Short Term Provisions 0.27 0.33 0.25 0.12 0.11 0.50 0.26 0.25 0.23 0.23 Total Liabilities 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.75 14.60 13.49 Net Block 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 9.17 9.17 Gross Block 11.62 11.55 11.45 11.24 9.83 9.45 11.04 10.85 10.68 10.44 Accumulated Depreciation 2.20 1.77 1.36 0.95 0.58 0.29 2.06 1.79 1.51 1.27 Non Current Assets 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 9.17 9.17 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 9.31 23.46 32.27 13.92 14.91 12.68 15.16 4.70 5.43 4.32 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.29 4.34 1.69 1.19 1.02 0.17 0.10 0.17 0.27 0.32 Sundry Debtors 7.17 17.22 29.71 12.03 12.98 11.46 13.98 3.65 4.10 3.34 Cash & Bank 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13 Other Current Assets 0.70 1.41 0.19 0.13 0.53 0.74 0.89 0.75 0.87 0.53 Short Term Loans & Adv. 0.20 0.05 0.43 0.44 0.43 0.59 0.89 0.75 0.87 0.53 Net Current Assets 7.82 6.71 4.79 3.36 3.92 3.53 1.93 -0.64 -1.31 -1.81 Total Assets 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.76 14.60 13.49

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity -0.22 1.11 0.89 1.26 0.46 0.71 0.14 0.01 0.21 -0.13 PBT 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 0.65 0.67 Adjustment 0.48 0.48 0.56 0.53 0.45 0.45 0.42 0.46 0.37 0.40 Changes in Working Capital -1.40 -0.62 -0.87 0.25 -0.07 -1.84 -0.96 -0.84 -0.52 -1.00 Cash after chg. in Working capital 0.10 1.79 1.15 1.37 0.97 0.91 0.44 0.35 0.50 0.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.21 -0.15 -0.19 Tax Paid -0.32 -0.68 -0.25 -0.11 -0.50 -0.20 -0.15 -0.13 -0.14 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.07 -0.10 -0.21 -1.41 -0.38 -0.48 -0.19 -0.17 -0.24 -0.30 Net Fixed Assets -0.07 -0.10 -0.21 -1.41 -0.38 1.59 -0.19 -0.17 -0.24 -0.30 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.00 0.00 0.00 0.00 -2.07 0.00 0.00 0.00 0.00 Cash from Financing Activity -0.01 -0.83 -0.57 -0.08 -0.02 -0.11 0.10 0.11 0.08 0.31 Net Cash Inflow / Outflow -0.30 0.18 0.12 -0.24 0.06 0.13 0.05 -0.05 0.05 -0.12 Opening Cash & Equivalents 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 Closing Cash & Equivalent 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 10.35 9.91 9.15 8.39 8.09 7.80 4.39 2.85 2.51 2.19 ROA 2.69% 3.28% 3.63% 1.99% 2.05% 7.81% 4.13% 4.14% 3.68% 3.93% ROE 4.24% 8.01% 8.46% 3.60% 3.64% 18.09% 13.28% 13.47% 13.53% 16.49% ROCE 6.23% 12.18% 10.12% 5.06% 5.13% 21.86% 14.04% 12.97% 12.09% 14.53% Fixed Asset Turnover 1.93 3.11 2.62 2.19 1.28 1.31 1.20 0.54 0.68 0.58 Receivable days 198.88 239.55 256.53 197.31 360.94 345.20 244.36 241.46 189.36 226.24 Inventory Days 45.97 30.82 17.72 17.48 17.59 3.56 3.64 13.70 15.17 16.41 Payable days 154.25 235.08 223.27 146.68 239.24 317.92 205.27 204.15 204.37 274.80 Cash Conversion Cycle 90.60 35.29 50.98 68.12 139.29 30.84 42.72 51.02 0.15 -32.15 Total Debt/Equity 0.03 0.03 0.08 0.12 0.12 0.11 0.19 0.64 0.70 0.78 Interest Cover 26.00 29.18 12.96 4.70 4.86 15.12 7.46 4.51 5.24 4.50

Top Investors:

starline equifin private limited

ksl and industries limited

kishor himmatsinh jhala

gom industries ltd

Annual Reports:

News Update:

Biofil Chem & Pharma - Quarterly Results
9th Aug 2022, 17:57 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback